| DAA757 |
Parkinsonian signs |
Physiological |
nervous system |
Human |
— |
— |
|
| DAA614 |
Parkinson's disease |
Pathological |
central nervous system |
Human |
— |
SeriesMorbidity |
|
| DAA1999 |
PARP activity increases with age in males |
Molecular |
skin |
Human |
PARP1 |
— |
|
| DAA348 |
parvin, gamma |
Molecular |
skeletal muscle |
Human |
PARVG |
3.0% Decrease Gene Expression Level |
|
| DAA481 |
PCTAIRE protein kinase 1 |
Molecular |
skeletal muscle |
Human |
PCTK1 |
4.0% Decrease Gene Expression Level |
|
| DAA168 |
PCTAIRE protein kinase 2 |
Molecular |
brain |
Human |
PCTK2 |
19.0% Decrease Gene Expression Level |
|
| DAA1970 |
Pdgfra (Platelete derived growth factor receptor a) mRNA levels decline |
Molecular |
pancreas |
Mouse |
Pdgfra |
— |
|
| DAA2407 |
PDZ and LIM domain 2 isoform 3 decreases with age |
Molecular |
dermis |
Human |
PDLIM2 |
17.3% Decrease DNA Methylation |
|
| DAA2456 |
PDZ and LIM domain 2 isoform 3 increases with age |
Molecular |
mesenchymal stem cell |
Human |
PDLIM2 |
43.9% Increase DNA Methylation |
|
| DAA170 |
PDZ and LIM domain 3 |
Molecular |
brain |
Human |
PDLIM3 |
22.0% Increase Gene Expression Level |
|
| DAA322 |
PDZ domain containing ring finger 3 |
Molecular |
skeletal muscle |
Human |
PDZRN3 |
3.0% Decrease Gene Expression Level |
|
| DAA793 |
Peak flow decreases |
Physiological |
lung |
Human |
— |
— |
|
| DAA1422 |
pellino 1 |
Molecular |
hippocampus |
Mouse |
Peli1 |
3.0% Increase Gene Expression Level |
|
| DAA636 |
Peptic ulcer |
Pathological |
stomach |
Human |
— |
SeriesMorbidity |
|
| DAA413 |
peptidase (mitochondrial processing) alpha |
Molecular |
skeletal muscle |
Human |
PMPCA |
3.0% Decrease Gene Expression Level |
|
| DAA1423 |
peptidoglycan recognition protein 1 |
Molecular |
hippocampus |
Mouse |
Pglyrp1 |
8.0% Increase Gene Expression Level |
|
| DAA446 |
peptidylprolyl isomerase A (cyclophilin A) |
Molecular |
skeletal muscle |
Human |
PPIA |
3.0% Increase Gene Expression Level |
|
| DAA433 |
peptidylprolyl isomerase A (cyclophilin A) |
Molecular |
skeletal muscle |
Human |
PPIA |
3.0% Increase Gene Expression Level |
|
| DAA389 |
peptidylprolyl isomerase C (cyclophilin C) |
Molecular |
skeletal muscle |
Human |
PPIC |
5.0% Decrease Gene Expression Level |
|
| DAA459 |
peptidylprolyl isomerase F |
Molecular |
skeletal muscle |
Human |
PPIF |
5.0% Decrease Gene Expression Level |
|
| DAA458 |
pericentriolar material 1 |
Molecular |
skeletal muscle |
Human |
PCM1 |
2.0% Increase Gene Expression Level |
|
| DAA1509 |
perilipin 4 |
Molecular |
liver |
Mouse |
Plin4 |
29.0% Decrease Gene Expression Level |
|
| DAA1354 |
periostin, osteoblast specific factor |
Molecular |
hematological system |
Mouse |
Postn |
39.0% Decrease Gene Expression Level |
|
| DAA1812 |
peripheral myelin protein 22 |
Molecular |
muscle |
Mouse |
Pmp22 |
3.0% Decrease Gene Expression Level |
|
| DAA417 |
peripheral myelin protein 22 |
Molecular |
skeletal muscle |
Human |
PMP22 |
6.0% Increase Gene Expression Level |
|